<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kleiboeker B</submitter><funding>BLRD VA</funding><funding>Nutrition Obesity Research Center, University of North Carolina</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIH</funding><funding>Diabetes Research Center, University of Washington</funding><funding>NIGMS NIH HHS</funding><pagination>101913</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10950804</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>82</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Adipose tissue mass is maintained by a balance between lipolysis and lipid storage. The contribution of adipose tissue lipogenesis to fat mass, especially in the setting of high-fat feeding, is considered minor. Here we investigated the effect of adipose-specific inactivation of the peroxisomal lipid synthetic protein PexRAP on fatty acid synthase (FASN)-mediated lipogenesis and its impact on adiposity and metabolic homeostasis.&lt;h4>Methods&lt;/h4>To explore the role of PexRAP in adipose tissue, we metabolically phenotyped mice with adipose-specific knockout of PexRAP. Bulk RNA sequencing was used to determine transcriptomic responses to PexRAP deletion and &lt;sup>14&lt;/sup>C-malonyl CoA allowed us to measure de novo lipogenic activity in adipose tissue of these mice. In vitro cell culture models were used to elucidate the mechanism of cellular responses to PexRAP deletion.&lt;h4>Results&lt;/h4>Adipose-specific PexRAP deletion promoted diet-induced obesity and insulin resistance through activation of de novo lipogenesis. Mechanistically, PexRAP inactivation inhibited the flux of carbons to ethanolamine plasmalogens. This increased the nuclear PC/PE ratio and promoted cholesterol mislocalization, resulting in activation of liver X receptor (LXR), a nuclear receptor known to be activated by increased intracellular cholesterol. LXR activation led to increased expression of the phospholipid remodeling enzyme LPCAT3 and induced FASN-mediated lipogenesis, which promoted diet-induced obesity and insulin resistance.&lt;h4>Conclusions&lt;/h4>These studies reveal an unexpected role for peroxisome-derived lipids in regulating LXR-dependent lipogenesis and suggest that activation of lipogenesis, combined with dietary lipid overload, exacerbates obesity and metabolic dysregulation.</pubmed_abstract><journal>Molecular metabolism</journal><pubmed_title>Adipose tissue peroxisomal lipid synthesis orchestrates obesity and insulin resistance through LXR-dependent lipogenesis.</pubmed_title><pmcid>PMC10950804</pmcid><funding_grant_id>T32DK007120</funding_grant_id><funding_grant_id>T32 DK007120</funding_grant_id><funding_grant_id>DK115867</funding_grant_id><funding_grant_id>DK132239</funding_grant_id><funding_grant_id>R01 DK115867</funding_grant_id><funding_grant_id>P30 DK020579</funding_grant_id><funding_grant_id>I01 BX003415</funding_grant_id><funding_grant_id>P30 DK056341</funding_grant_id><funding_grant_id>DK118333</funding_grant_id><funding_grant_id>R01 HL125838</funding_grant_id><funding_grant_id>P60 DK020579</funding_grant_id><funding_grant_id>DK020579</funding_grant_id><funding_grant_id>DK056341</funding_grant_id><funding_grant_id>R01 DK132239</funding_grant_id><funding_grant_id>P41 GM103422</funding_grant_id><funding_grant_id>R01 DK133344</funding_grant_id><funding_grant_id>R01 DK118333</funding_grant_id><funding_grant_id>R01 DK131188</funding_grant_id><funding_grant_id>R01 HL159461</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Hsu FF</pubmed_authors><pubmed_authors>Semenkovich CF</pubmed_authors><pubmed_authors>Kleiboeker B</pubmed_authors><pubmed_authors>Tan M</pubmed_authors><pubmed_authors>Hu D</pubmed_authors><pubmed_authors>Lodhi IJ</pubmed_authors><pubmed_authors>Razani B</pubmed_authors><pubmed_authors>Lu D</pubmed_authors><pubmed_authors>He A</pubmed_authors><pubmed_authors>Goodarzi P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adipose tissue peroxisomal lipid synthesis orchestrates obesity and insulin resistance through LXR-dependent lipogenesis.</name><description>&lt;h4>Objective&lt;/h4>Adipose tissue mass is maintained by a balance between lipolysis and lipid storage. The contribution of adipose tissue lipogenesis to fat mass, especially in the setting of high-fat feeding, is considered minor. Here we investigated the effect of adipose-specific inactivation of the peroxisomal lipid synthetic protein PexRAP on fatty acid synthase (FASN)-mediated lipogenesis and its impact on adiposity and metabolic homeostasis.&lt;h4>Methods&lt;/h4>To explore the role of PexRAP in adipose tissue, we metabolically phenotyped mice with adipose-specific knockout of PexRAP. Bulk RNA sequencing was used to determine transcriptomic responses to PexRAP deletion and &lt;sup>14&lt;/sup>C-malonyl CoA allowed us to measure de novo lipogenic activity in adipose tissue of these mice. In vitro cell culture models were used to elucidate the mechanism of cellular responses to PexRAP deletion.&lt;h4>Results&lt;/h4>Adipose-specific PexRAP deletion promoted diet-induced obesity and insulin resistance through activation of de novo lipogenesis. Mechanistically, PexRAP inactivation inhibited the flux of carbons to ethanolamine plasmalogens. This increased the nuclear PC/PE ratio and promoted cholesterol mislocalization, resulting in activation of liver X receptor (LXR), a nuclear receptor known to be activated by increased intracellular cholesterol. LXR activation led to increased expression of the phospholipid remodeling enzyme LPCAT3 and induced FASN-mediated lipogenesis, which promoted diet-induced obesity and insulin resistance.&lt;h4>Conclusions&lt;/h4>These studies reveal an unexpected role for peroxisome-derived lipids in regulating LXR-dependent lipogenesis and suggest that activation of lipogenesis, combined with dietary lipid overload, exacerbates obesity and metabolic dysregulation.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-07-03T03:21:31.67Z</modification><creation>2025-04-06T07:47:32.469Z</creation></dates><accession>S-EPMC10950804</accession><cross_references><pubmed>38458567</pubmed><doi>10.1016/j.molmet.2024.101913</doi></cross_references></HashMap>